Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6667 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6635 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD171 |
Discontinued |
0.6536 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6535 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6507 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6502 |
Remote Similarity |
NPD8004 |
Discontinued |
0.65 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6481 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.645 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6435 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6422 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6373 |
Remote Similarity |
NPD7722 |
Suspended |
0.6368 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.6368 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.6368 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.6368 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.6354 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6338 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6321 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.632 |
Remote Similarity |
NPD7856 |
Phase 2 |
0.632 |
Remote Similarity |
NPD7857 |
Phase 3 |
0.6318 |
Remote Similarity |
NPD3590 |
Clinical (unspecified phase) |
0.6306 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6306 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6283 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6278 |
Remote Similarity |
NPD5703 |
Discontinued |
0.6244 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6244 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6243 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6221 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6221 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6209 |
Remote Similarity |
NPD4240 |
Approved |
0.6199 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.6197 |
Remote Similarity |
NPD7103 |
Approved |
0.6186 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6183 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6176 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6171 |
Remote Similarity |
NPD248 |
Discontinued |
0.6164 |
Remote Similarity |
NPD6992 |
Phase 2 |
0.6129 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.6127 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6127 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6124 |
Remote Similarity |
NPD7935 |
Phase 2 |
0.6106 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.6103 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6103 |
Remote Similarity |
NPD7988 |
Suspended |
0.6099 |
Remote Similarity |
NPD5827 |
Discontinued |
0.6087 |
Remote Similarity |
NPD4306 |
Phase 1 |
0.6085 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6073 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6073 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6067 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6061 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6056 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6056 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6056 |
Remote Similarity |
NPD4142 |
Discontinued |
0.6044 |
Remote Similarity |
NPD3696 |
Approved |
0.6044 |
Remote Similarity |
NPD3695 |
Approved |
0.6044 |
Remote Similarity |
NPD193 |
Suspended |
0.604 |
Remote Similarity |
NPD4716 |
Approved |
0.6034 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6025 |
Remote Similarity |
NPD7850 |
Discontinued |
0.6025 |
Remote Similarity |
NPD7851 |
Phase 1 |
0.6023 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.602 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.602 |
Remote Similarity |
NPD1313 |
Approved |
0.6019 |
Remote Similarity |
NPD5458 |
Discontinued |
0.601 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD34 |
Approved |
0.6 |
Remote Similarity |
NPD4714 |
Approved |
0.6 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.5991 |
Remote Similarity |
NPD6772 |
Clinical (unspecified phase) |
0.5982 |
Remote Similarity |
NPD5072 |
Discontinued |
0.5981 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.5978 |
Remote Similarity |
NPD185 |
Approved |
0.5972 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.5971 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.5964 |
Remote Similarity |
NPD7423 |
Phase 2 |
0.5951 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5951 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5946 |
Remote Similarity |
NPD6528 |
Phase 1 |
0.5946 |
Remote Similarity |
NPD7188 |
Phase 3 |
0.5944 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.5936 |
Remote Similarity |
NPD7409 |
Clinical (unspecified phase) |
0.5936 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5933 |
Remote Similarity |
NPD7709 |
Discontinued |
0.5931 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.5931 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5923 |
Remote Similarity |
NPD6840 |
Approved |
0.592 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.5919 |
Remote Similarity |
NPD6957 |
Approved |
0.5919 |
Remote Similarity |
NPD6711 |
Approved |
0.5919 |
Remote Similarity |
NPD6958 |
Approved |
0.5919 |
Remote Similarity |
NPD6643 |
Discontinued |
0.5917 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5915 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5914 |
Remote Similarity |
NPD250 |
Approved |
0.5914 |
Remote Similarity |
NPD249 |
Approved |
0.5914 |
Remote Similarity |
NPD166 |
Approved |
0.5913 |
Remote Similarity |
NPD7504 |
Discontinued |
0.5909 |
Remote Similarity |
NPD1215 |
Discontinued |
0.5895 |
Remote Similarity |
NPD1273 |
Discontinued |
0.5894 |
Remote Similarity |
NPD4902 |
Discontinued |
0.5893 |
Remote Similarity |
NPD7471 |
Discontinued |
0.5873 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.5872 |
Remote Similarity |
NPD6403 |
Clinical (unspecified phase) |
0.5871 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.5865 |
Remote Similarity |
NPD3501 |
Phase 2 |
0.5859 |
Remote Similarity |
NPD8120 |
Approved |
0.5859 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.5859 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.5855 |
Remote Similarity |
NPD6970 |
Phase 2 |
0.5851 |
Remote Similarity |
NPD186 |
Discovery |
0.5851 |
Remote Similarity |
NPD195 |
Approved |
0.5845 |
Remote Similarity |
NPD1197 |
Approved |
0.5842 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.5841 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.5841 |
Remote Similarity |
NPD3287 |
Clinical (unspecified phase) |
0.5841 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.583 |
Remote Similarity |
NPD4341 |
Clinical (unspecified phase) |
0.5829 |
Remote Similarity |
NPD3431 |
Approved |
0.5829 |
Remote Similarity |
NPD3430 |
Approved |
0.5825 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.5822 |
Remote Similarity |
NPD8257 |
Approved |
0.5822 |
Remote Similarity |
NPD8256 |
Approved |
0.5822 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.5821 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.5818 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.5818 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.5817 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5815 |
Remote Similarity |
NPD6856 |
Discontinued |
0.5813 |
Remote Similarity |
NPD5843 |
Discontinued |
0.5811 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.5809 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.5806 |
Remote Similarity |
NPD4872 |
Clinical (unspecified phase) |
0.5806 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5805 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.5805 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.5803 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.58 |
Remote Similarity |
NPD5052 |
Clinical (unspecified phase) |
0.5792 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.5787 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.5785 |
Remote Similarity |
NPD4896 |
Clinical (unspecified phase) |
0.5785 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.5783 |
Remote Similarity |
NPD3938 |
Phase 1 |
0.5782 |
Remote Similarity |
NPD1286 |
Suspended |
0.578 |
Remote Similarity |
NPD2364 |
Suspended |
0.5773 |
Remote Similarity |
NPD3906 |
Approved |
0.5771 |
Remote Similarity |
NPD8105 |
Discontinued |
0.5767 |
Remote Similarity |
NPD5885 |
Approved |
0.5766 |
Remote Similarity |
NPD3013 |
Phase 3 |
0.5766 |
Remote Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.5766 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.5766 |
Remote Similarity |
NPD5116 |
Phase 1 |
0.5762 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.576 |
Remote Similarity |
NPD6307 |
Clinical (unspecified phase) |
0.576 |
Remote Similarity |
NPD5949 |
Phase 3 |
0.5759 |
Remote Similarity |
NPD7277 |
Approved |
0.5759 |
Remote Similarity |
NPD7276 |
Approved |
0.5759 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.5759 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.5758 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.5758 |
Remote Similarity |
NPD2480 |
Clinical (unspecified phase) |
0.5758 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.5756 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.5753 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.5752 |
Remote Similarity |
NPD4893 |
Phase 3 |
0.5751 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.5751 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.575 |
Remote Similarity |
NPD4440 |
Clinical (unspecified phase) |
0.575 |
Remote Similarity |
NPD6573 |
Phase 3 |
0.575 |
Remote Similarity |
NPD6572 |
Phase 2 |
0.575 |
Remote Similarity |
NPD6794 |
Approved |
0.575 |
Remote Similarity |
NPD7067 |
Approved |
0.575 |
Remote Similarity |
NPD7068 |
Approved |
0.575 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.5747 |
Remote Similarity |
NPD5529 |
Phase 1 |
0.5747 |
Remote Similarity |
NPD5528 |
Clinical (unspecified phase) |
0.5745 |
Remote Similarity |
NPD7415 |
Suspended |
0.5744 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.5744 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5743 |
Remote Similarity |
NPD2993 |
Clinical (unspecified phase) |
0.5742 |
Remote Similarity |
NPD5757 |
Discontinued |
0.5739 |
Remote Similarity |
NPD5045 |
Phase 2 |
0.5739 |
Remote Similarity |
NPD7202 |
Clinical (unspecified phase) |
0.5735 |
Remote Similarity |
NPD6281 |
Approved |
0.5735 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.5734 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.5733 |
Remote Similarity |
NPD6165 |
Phase 2 |
0.5733 |
Remote Similarity |
NPD6164 |
Phase 2 |
0.5733 |
Remote Similarity |
NPD7694 |
Discontinued |
0.5729 |
Remote Similarity |
NPD283 |
Approved |
0.5728 |
Remote Similarity |
NPD3403 |
Clinical (unspecified phase) |
0.5727 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.5727
|
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |